Dyne Therapeutics Stock Market Value
| DYN Stock | USD 15.55 0.00 0.00% |
| Symbol | Dyne |
Will Biotechnology sector continue expanding? Could Dyne diversify its offerings? Factors like these will boost the valuation of Dyne Therapeutics. Projected growth potential of Dyne fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dyne Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dyne Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dyne Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dyne Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Dyne Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dyne Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dyne Therapeutics.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Dyne Therapeutics on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Dyne Therapeutics or generate 0.0% return on investment in Dyne Therapeutics over 90 days. Dyne Therapeutics is related to or competes with Ultragenyx, Soleno Therapeutics, Centessa Pharmaceuticals, Xenon Pharmaceuticals, Apogee Therapeutics, Ascentage Pharma, and Mirum Pharmaceuticals. Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therape... More
Dyne Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dyne Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dyne Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 26.4 | |||
| Value At Risk | (5.89) | |||
| Potential Upside | 7.01 |
Dyne Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dyne Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dyne Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dyne Therapeutics historical prices to predict the future Dyne Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.28) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.27) | |||
| Mean Deviation | 3.1 | |||
| Coefficient Of Variation | (2,465) | |||
| Standard Deviation | 4.26 | |||
| Variance | 18.18 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.28) | |||
| Maximum Drawdown | 26.4 | |||
| Value At Risk | (5.89) | |||
| Potential Upside | 7.01 | |||
| Skewness | (0.63) | |||
| Kurtosis | 2.84 |
Dyne Therapeutics Backtested Returns
Dyne Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0961, which denotes the company had a -0.0961 % return per unit of risk over the last 3 months. Dyne Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dyne Therapeutics' Variance of 18.18, mean deviation of 3.1, and Standard Deviation of 4.26 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.65, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dyne Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dyne Therapeutics is expected to be smaller as well. At this point, Dyne Therapeutics has a negative expected return of -0.4%. Please make sure to confirm Dyne Therapeutics' variance, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Dyne Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.13 |
Insignificant predictability
Dyne Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between Dyne Therapeutics time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dyne Therapeutics price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Dyne Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.87 |
Pair Trading with Dyne Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
Moving against Dyne Stock
| 0.81 | DRTS | Alpha Tau Medical | PairCorr |
| 0.74 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.68 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.67 | VALN | Valneva SE ADR | PairCorr |
| 0.65 | 6C1 | CytomX Therapeutics | PairCorr |
The ability to find closely correlated positions to Dyne Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne Therapeutics to buy it.
The correlation of Dyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dyne Therapeutics Correlation, Dyne Therapeutics Volatility and Dyne Therapeutics Performance module to complement your research on Dyne Therapeutics. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Dyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.